Abstract A026: GenAI and Physics Assisted Methods for the Design and Development of USP1 Inhibitors
Bibliographic record
Abstract
Abstract GenAI enables the exploration of vast chemical spaces that would be impractical through traditional methods. Its ability to learn from complex datasets and generate novel compound structures makes it a game-changer in early-stage drug discovery. Generative Artificial Intelligence (GenAI) is transforming drug discovery, USP1 (ubiquitin-specific protease 1) plays a key role in DNA damage repair, making it an attractive target for cancer therapies. At VeGen, AI-driven platforms have been instrumental in designing next-generation USP1 inhibitors. By leveraging generative and predictive models, we accelerate the discovery process—rapidly designing and optimizing molecules with high potency, selectivity, and drug-like properties. An early promising hit with strong chemical diversity has been identified, demonstrating potent USP1 inhibition and favorable selectivity. To further refine selectivity, AlphaFold-based structural modelling has been integrated into the workflow, allowing detailed predictions of target-ligand interactions and off-target risk assessment alongside AI-driven design. This effort employs a closed-loop system—Bridging Computational Predictions with Experimental Validation—which not only streamlines the workflow but also minimizes experimental risk by prioritizing the most promising candidates. These innovations underscore the power of AI to reduce development timelines, lower costs, and enhance therapeutic potential, particularly in overcoming resistance to PARP inhibitors—a significant challenge in cancer treatment. Citation Format: Appaji Baburao. Mandhare, Prashant Bhavar, Uday Surampudi, Rupesh Chikale. GenAI and Physics Assisted Methods for the Design and Development of USP1 Inhibitors [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Artificial Intelligence and Machine Learning; 2025 Jul 10-12; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(13_Suppl):Abstract nr A026.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.001 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.001 | 0.000 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.001 | 0.001 |
| Insufficient payload (model declined to judge) | 0.009 | 0.002 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".